APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mesalazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchMesalazine API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine API Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Mesalazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine API Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine API Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Mesalazine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesalazine API include YC Biotech (Jiangsu), Lianyungang Fengheng Biopharm, Hangzhou Brother, Syntese A/S, PharmaZell, Lasa Loboratory, Ishita Active Pharma Ingredients, Ipca Laboratories and Erregierre SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Mesalazine API output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Mesalazine API by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Mesalazine API market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalazine API and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalazine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalazine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalazine API Segment by Company

YC Biotech (Jiangsu)

Lianyungang Fengheng Biopharm

Hangzhou Brother

Syntese A/S

PharmaZell

Lasa Loboratory

Ishita Active Pharma Ingredients

Ipca Laboratories

Erregierre SpA

Divis Laboratories

CTX Lifescience

Corden Pharma Bergamo

Chemi SpA

Cambrex Corporation

Mesalazine API Segment by Type

Purity ≥ 99%

Purity ≥ 98%

Purity ≥ 97%

Mesalazine API Segment by Application

Suppository

Tablets

Granule

Capsules

Enema

Others

Mesalazine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalazine API market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesalazine API industry.

Chapter 3: Detailed analysis of Mesalazine API market competition landscape. Including Mesalazine API manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Mesalazine API by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Mesalazine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Mesalazine API Industry Trends Table 2. Mesalazine API Industry Drivers Table 3. Mesalazine API Industry Opportunities and Challenges Table 4. Mesalazine API Industry Restraints Table 5. Global Mesalazine API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mesalazine API Production Value Share by Manufacturers (2021-2026) Table 7. Global Mesalazine API Production by Manufacturers (t) & (2021-2026) Table 8. Global Mesalazine API Production Market Share by Manufacturers Table 9. Global Mesalazine API Average Price (USD/kg) of Manufacturers (2021-2026) Table 10. Global Mesalazine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mesalazine API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mesalazine API Manufacturers, Product Type & Application Table 13. Global Mesalazine API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalazine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Purity ≥ 99% Table 17. Major Manufacturers of Purity ≥ 98% Table 18. Major Manufacturers of Purity ≥ 97% Table 19. Global Mesalazine API Production by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Mesalazine API Production by Type (2021-2026) & (t) Table 21. Global Mesalazine API Production by Type (2027-2032) & (t) Table 22. Global Mesalazine API Production Market Share by Type (2021-2026) Table 23. Global Mesalazine API Production Market Share by Type (2027-2032) Table 24. Global Mesalazine API Production Value by Type 2021 VS 2025 VS 2032 (t) Table 25. Global Mesalazine API Production Value by Type (2021-2026) & (t) Table 26. Global Mesalazine API Production Value by Type (2027-2032) & (t) Table 27. Global Mesalazine API Production Value Market Share by Type (2021-2026) Table 28. Global Mesalazine API Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Suppository Table 30. Major Manufacturers of Tablets Table 31. Major Manufacturers of Granule Table 32. Major Manufacturers of Capsules Table 33. Major Manufacturers of Enema Table 34. Major Manufacturers of Others Table 35. Global Mesalazine API Production by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Mesalazine API Production by Application (2021-2026) & (t) Table 37. Global Mesalazine API Production by Application (2027-2032) & (t) Table 38. Global Mesalazine API Production Market Share by Application (2021-2026) Table 39. Global Mesalazine API Production Market Share by Application (2027-2032) Table 40. Global Mesalazine API Production Value by Application 2021 VS 2025 VS 2032 (t) Table 41. Global Mesalazine API Production Value by Application (2021-2026) & (t) Table 42. Global Mesalazine API Production Value by Application (2027-2032) & (t) Table 43. Global Mesalazine API Production Value Market Share by Application (2021-2026) Table 44. Global Mesalazine API Production Value Market Share by Application (2027-2032) Table 45. YC Biotech (Jiangsu) Company Information Table 46. YC Biotech (Jiangsu) Business Overview Table 47. YC Biotech (Jiangsu) Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 48. YC Biotech (Jiangsu) Mesalazine API Product Portfolio Table 49. YC Biotech (Jiangsu) Recent Development Table 50. Lianyungang Fengheng Biopharm Company Information Table 51. Lianyungang Fengheng Biopharm Business Overview Table 52. Lianyungang Fengheng Biopharm Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 53. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio Table 54. Lianyungang Fengheng Biopharm Recent Development Table 55. Hangzhou Brother Company Information Table 56. Hangzhou Brother Business Overview Table 57. Hangzhou Brother Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 58. Hangzhou Brother Mesalazine API Product Portfolio Table 59. Hangzhou Brother Recent Development Table 60. Syntese A/S Company Information Table 61. Syntese A/S Business Overview Table 62. Syntese A/S Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 63. Syntese A/S Mesalazine API Product Portfolio Table 64. Syntese A/S Recent Development Table 65. PharmaZell Company Information Table 66. PharmaZell Business Overview Table 67. PharmaZell Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 68. PharmaZell Mesalazine API Product Portfolio Table 69. PharmaZell Recent Development Table 70. Lasa Loboratory Company Information Table 71. Lasa Loboratory Business Overview Table 72. Lasa Loboratory Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 73. Lasa Loboratory Mesalazine API Product Portfolio Table 74. Lasa Loboratory Recent Development Table 75. Ishita Active Pharma Ingredients Company Information Table 76. Ishita Active Pharma Ingredients Business Overview Table 77. Ishita Active Pharma Ingredients Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 78. Ishita Active Pharma Ingredients Mesalazine API Product Portfolio Table 79. Ishita Active Pharma Ingredients Recent Development Table 80. Ipca Laboratories Company Information Table 81. Ipca Laboratories Business Overview Table 82. Ipca Laboratories Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 83. Ipca Laboratories Mesalazine API Product Portfolio Table 84. Ipca Laboratories Recent Development Table 85. Erregierre SpA Company Information Table 86. Erregierre SpA Business Overview Table 87. Erregierre SpA Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 88. Erregierre SpA Mesalazine API Product Portfolio Table 89. Erregierre SpA Recent Development Table 90. Divis Laboratories Company Information Table 91. Divis Laboratories Business Overview Table 92. Divis Laboratories Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 93. Divis Laboratories Mesalazine API Product Portfolio Table 94. Divis Laboratories Recent Development Table 95. CTX Lifescience Company Information Table 96. CTX Lifescience Business Overview Table 97. CTX Lifescience Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 98. CTX Lifescience Mesalazine API Product Portfolio Table 99. CTX Lifescience Recent Development Table 100. Corden Pharma Bergamo Company Information Table 101. Corden Pharma Bergamo Business Overview Table 102. Corden Pharma Bergamo Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 103. Corden Pharma Bergamo Mesalazine API Product Portfolio Table 104. Corden Pharma Bergamo Recent Development Table 105. Chemi SpA Company Information Table 106. Chemi SpA Business Overview Table 107. Chemi SpA Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 108. Chemi SpA Mesalazine API Product Portfolio Table 109. Chemi SpA Recent Development Table 110. Cambrex Corporation Company Information Table 111. Cambrex Corporation Business Overview Table 112. Cambrex Corporation Mesalazine API Production (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 113. Cambrex Corporation Mesalazine API Product Portfolio Table 114. Cambrex Corporation Recent Development Table 115. Global Mesalazine API Production by Region: 2021 VS 2025 VS 2032 (t) Table 116. Global Mesalazine API Production by Region (2021-2026) & (t) Table 117. Global Mesalazine API Production Market Share by Region (2021-2026) Table 118. Global Mesalazine API Production Forecast by Region (2027-2032) & (t) Table 119. Global Mesalazine API Production Market Share Forecast by Region (2027-2032) Table 120. Global Mesalazine API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 121. Global Mesalazine API Production Value by Region (2021-2026) & (US$ Million) Table 122. Global Mesalazine API Production Value Share by Region (2021-2026) Table 123. Global Mesalazine API Production Value by Region (2027-2032) & (US$ Million) Table 124. Global Mesalazine API Production Value Share by Region: (2027-2032) & (US$ Million) Table 125. Global Mesalazine API Market Average Price (USD/kg) by Region (2021-2026) Table 126. Global Mesalazine API Market Average Price (USD/kg) by Region (2027-2032) Table 127. Global Mesalazine API Consumption by Region: 2021 VS 2025 VS 2032 (t) Table 128. Global Mesalazine API Consumption by Region (2021-2026) & (t) Table 129. Global Mesalazine API Consumption Market Share by Region (2021-2026) Table 130. Global Mesalazine API Consumption Forecasted by Region (2027-2032) & (t) Table 131. Global Mesalazine API Consumption Forecasted Market Share by Region (2027-2032) Table 132. North America Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 133. North America Mesalazine API Consumption by Country (2021-2026) & (t) Table 134. North America Mesalazine API Consumption by Country (2027-2032) & (t) Table 135. Europe Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 136. Europe Mesalazine API Consumption by Country (2021-2026) & (t) Table 137. Europe Mesalazine API Consumption by Country (2027-2032) & (t) Table 138. Asia Pacific Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 139. Asia Pacific Mesalazine API Consumption by Country (2021-2026) & (t) Table 140. Asia Pacific Mesalazine API Consumption by Country (2027-2032) & (t) Table 141. South America Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 142. South America Mesalazine API Consumption by Country (2021-2026) & (t) Table 143. South America Mesalazine API Consumption by Country (2027-2032) & (t) Table 144. Middle East & Africa Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 145. Middle East & Africa Mesalazine API Consumption by Country (2021-2026) & (t) Table 146. Middle East & Africa Mesalazine API Consumption by Country (2027-2032) & (t) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Mesalazine API Distributors List Table 150. Mesalazine API Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Mesalazine API Product Image Figure 2. Global Mesalazine API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine API Production Value (2021-2032) & (US$ Million) Figure 4. Global Mesalazine API Production Capacity (2021-2032) & (t) Figure 5. Global Mesalazine API Production (2021-2032) & (t) Figure 6. Global Mesalazine API Average Price (USD/kg) & (2021-2032) Figure 7. Global Top 5 and 10 Mesalazine API Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥ 99% Image Figure 10. Purity ≥ 98% Image Figure 11. Purity ≥ 97% Image Figure 12. Global Mesalazine API Production by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Mesalazine API Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global Mesalazine API Production Market Share by Type (2021-2032) Figure 15. Global Mesalazine API Production Value by Type (2021 VS 2025 VS 2032) & (t) Figure 16. Global Mesalazine API Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mesalazine API Production Value Share by Type (2021-2032) Figure 18. Suppository Image Figure 19. Tablets Image Figure 20. Granule Image Figure 21. Capsules Image Figure 22. Enema Image Figure 23. Others Image Figure 24. Global Mesalazine API Production by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Mesalazine API Production Market Share 2021 VS 2025 VS 2032 Figure 26. Global Mesalazine API Production Market Share by Application (2021-2032) Figure 27. Global Mesalazine API Production Value by Application (2021 VS 2025 VS 2032) & (t) Figure 28. Global Mesalazine API Production Value Share 2021 VS 2025 VS 2032 Figure 29. Global Mesalazine API Production Value Share by Application (2021-2032) Figure 30. Global Mesalazine API Production by Region: 2021 VS 2025 VS 2032 (t) Figure 31. Global Mesalazine API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Mesalazine API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Mesalazine API Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Mesalazine API Production Value (2021-2032) & (US$ Million) Figure 35. Europe Mesalazine API Production Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Mesalazine API Production Value (2021-2032) & (US$ Million) Figure 37. South America Mesalazine API Production Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Mesalazine API Production Value (2021-2032) & (US$ Million) Figure 39. North America Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 40. North America Mesalazine API Consumption Market Share by Country (2021-2032) Figure 41. U.S. Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 42. Canada Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 43. Mexico Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 44. Europe Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 45. Europe Mesalazine API Consumption Market Share by Country (2021-2032) Figure 46. Germany Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 47. France Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 48. U.K. Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 49. Italy Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 50. Netherlands Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 51. Asia Pacific Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 52. Asia Pacific Mesalazine API Consumption Market Share by Country (2021-2032) Figure 53. China Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 54. Japan Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 55. South Korea Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 56. Southeast Asia Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 57. India Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 58. Australia Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 59. South America Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 60. South America Mesalazine API Consumption Market Share by Country (2021-2032) Figure 61. Brazil Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 62. Argentina Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 63. Chile Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 64. Middle East & Africa Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 65. Middle East & Africa Mesalazine API Consumption Market Share by Country (2021-2032) Figure 66. Egypt Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 67. South Africa Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 68. Israel Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 69. Türkiye Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 70. GCC Countries Mesalazine API Consumption and Growth Rate (2021-2032) & (t) Figure 71. Mesalazine API Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Mesalazine API Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 99%
  • Purity ≥ 98%
  • Purity ≥ 97%
Applications
  • Suppository
  • Tablets
  • Granule
  • Capsules
  • Enema
  • Others
Companies covered
  • YC Biotech (Jiangsu)
  • Lianyungang Fengheng Biopharm
  • Hangzhou Brother
  • Syntese A/S
  • PharmaZell
  • Lasa Loboratory
  • Ishita Active Pharma Ingredients
  • Ipca Laboratories
  • Erregierre SpA
  • Divis Laboratories
  • CTX Lifescience
  • Corden Pharma Bergamo
  • Chemi SpA
  • Cambrex Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine API Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalazine API Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Mesalazine API Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Mesalazine API Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Mesalazine API Market Dynamics
  1. 2.1 Mesalazine API Industry Trends
  2. 2.2 Mesalazine API Industry Drivers
  3. 2.3 Mesalazine API Industry Opportunities and Challenges
  4. 2.4 Mesalazine API Industry Restraints
3 Mesalazine API Market by Manufacturers
  1. 3.1 Global Mesalazine API Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Mesalazine API Production by Manufacturers (2021-2026)
  3. 3.3 Global Mesalazine API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Mesalazine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalazine API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mesalazine API Manufacturers, Product Type & Application
  7. 3.7 Global Mesalazine API Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalazine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalazine API Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Mesalazine API Tier 1, Tier 2, and Tier 3
4 Mesalazine API Market by Type
  1. 4.1 Mesalazine API Type Introduction
  2. 4.1.1 Purity ≥ 99%
  3. 4.1.2 Purity ≥ 98%
  4. 4.1.3 Purity ≥ 97%
  5. 4.2 Global Mesalazine API Production by Type
  6. 4.2.1 Global Mesalazine API Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalazine API Production by Type (2021-2032)
  8. 4.2.3 Global Mesalazine API Production Market Share by Type (2021-2032)
  9. 4.3 Global Mesalazine API Production Value by Type
  10. 4.3.1 Global Mesalazine API Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalazine API Production Value by Type (2021-2032)
  12. 4.3.3 Global Mesalazine API Production Value Market Share by Type (2021-2032)
5 Mesalazine API Market by Application
  1. 5.1 Mesalazine API Application Introduction
  2. 5.1.1 Suppository
  3. 5.1.2 Tablets
  4. 5.1.3 Granule
  5. 5.1.4 Capsules
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalazine API Production by Application
  9. 5.2.1 Global Mesalazine API Production by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Mesalazine API Production by Application (2021-2032)
  11. 5.2.3 Global Mesalazine API Production Market Share by Application (2021-2032)
  12. 5.3 Global Mesalazine API Production Value by Application
  13. 5.3.1 Global Mesalazine API Production Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Mesalazine API Production Value by Application (2021-2032)
  15. 5.3.3 Global Mesalazine API Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 YC Biotech (Jiangsu)
  2. 6.1.1 YC Biotech (Jiangsu) Company Information
  3. 6.1.2 YC Biotech (Jiangsu) Business Overview
  4. 6.1.3 YC Biotech (Jiangsu) Mesalazine API Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 YC Biotech (Jiangsu) Mesalazine API Product Portfolio
  6. 6.1.5 YC Biotech (Jiangsu) Recent Developments
  7. 6.2 Lianyungang Fengheng Biopharm
  8. 6.2.1 Lianyungang Fengheng Biopharm Company Information
  9. 6.2.2 Lianyungang Fengheng Biopharm Business Overview
  10. 6.2.3 Lianyungang Fengheng Biopharm Mesalazine API Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio
  12. 6.2.5 Lianyungang Fengheng Biopharm Recent Developments
  13. 6.3 Hangzhou Brother
  14. 6.3.1 Hangzhou Brother Company Information
  15. 6.3.2 Hangzhou Brother Business Overview
  16. 6.3.3 Hangzhou Brother Mesalazine API Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Hangzhou Brother Mesalazine API Product Portfolio
  18. 6.3.5 Hangzhou Brother Recent Developments
  19. 6.4 Syntese A/S
  20. 6.4.1 Syntese A/S Company Information
  21. 6.4.2 Syntese A/S Business Overview
  22. 6.4.3 Syntese A/S Mesalazine API Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Syntese A/S Mesalazine API Product Portfolio
  24. 6.4.5 Syntese A/S Recent Developments
  25. 6.5 PharmaZell
  26. 6.5.1 PharmaZell Company Information
  27. 6.5.2 PharmaZell Business Overview
  28. 6.5.3 PharmaZell Mesalazine API Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 PharmaZell Mesalazine API Product Portfolio
  30. 6.5.5 PharmaZell Recent Developments
  31. 6.6 Lasa Loboratory
  32. 6.6.1 Lasa Loboratory Company Information
  33. 6.6.2 Lasa Loboratory Business Overview
  34. 6.6.3 Lasa Loboratory Mesalazine API Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Lasa Loboratory Mesalazine API Product Portfolio
  36. 6.6.5 Lasa Loboratory Recent Developments
  37. 6.7 Ishita Active Pharma Ingredients
  38. 6.7.1 Ishita Active Pharma Ingredients Company Information
  39. 6.7.2 Ishita Active Pharma Ingredients Business Overview
  40. 6.7.3 Ishita Active Pharma Ingredients Mesalazine API Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Ishita Active Pharma Ingredients Mesalazine API Product Portfolio
  42. 6.7.5 Ishita Active Pharma Ingredients Recent Developments
  43. 6.8 Ipca Laboratories
  44. 6.8.1 Ipca Laboratories Company Information
  45. 6.8.2 Ipca Laboratories Business Overview
  46. 6.8.3 Ipca Laboratories Mesalazine API Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Ipca Laboratories Mesalazine API Product Portfolio
  48. 6.8.5 Ipca Laboratories Recent Developments
  49. 6.9 Erregierre SpA
  50. 6.9.1 Erregierre SpA Company Information
  51. 6.9.2 Erregierre SpA Business Overview
  52. 6.9.3 Erregierre SpA Mesalazine API Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Erregierre SpA Mesalazine API Product Portfolio
  54. 6.9.5 Erregierre SpA Recent Developments
  55. 6.10 Divis Laboratories
  56. 6.10.1 Divis Laboratories Company Information
  57. 6.10.2 Divis Laboratories Business Overview
  58. 6.10.3 Divis Laboratories Mesalazine API Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Divis Laboratories Mesalazine API Product Portfolio
  60. 6.10.5 Divis Laboratories Recent Developments
  61. 6.11 CTX Lifescience
  62. 6.11.1 CTX Lifescience Company Information
  63. 6.11.2 CTX Lifescience Business Overview
  64. 6.11.3 CTX Lifescience Mesalazine API Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 CTX Lifescience Mesalazine API Product Portfolio
  66. 6.11.5 CTX Lifescience Recent Developments
  67. 6.12 Corden Pharma Bergamo
  68. 6.12.1 Corden Pharma Bergamo Company Information
  69. 6.12.2 Corden Pharma Bergamo Business Overview
  70. 6.12.3 Corden Pharma Bergamo Mesalazine API Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Corden Pharma Bergamo Mesalazine API Product Portfolio
  72. 6.12.5 Corden Pharma Bergamo Recent Developments
  73. 6.13 Chemi SpA
  74. 6.13.1 Chemi SpA Company Information
  75. 6.13.2 Chemi SpA Business Overview
  76. 6.13.3 Chemi SpA Mesalazine API Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 Chemi SpA Mesalazine API Product Portfolio
  78. 6.13.5 Chemi SpA Recent Developments
  79. 6.14 Cambrex Corporation
  80. 6.14.1 Cambrex Corporation Company Information
  81. 6.14.2 Cambrex Corporation Business Overview
  82. 6.14.3 Cambrex Corporation Mesalazine API Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 Cambrex Corporation Mesalazine API Product Portfolio
  84. 6.14.5 Cambrex Corporation Recent Developments
7 Global Mesalazine API Production by Region
  1. 7.1 Global Mesalazine API Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesalazine API Production by Region (2021-2032)
  3. 7.2.1 Global Mesalazine API Production by Region (2021-2026)
  4. 7.2.2 Global Mesalazine API Production Forecast by Region (2027-2032)
  5. 7.3 Global Mesalazine API Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Mesalazine API Production Value by Region (2021-2032)
  7. 7.4.1 Global Mesalazine API Production Value by Region (2021-2026)
  8. 7.4.2 Global Mesalazine API Production Value by Region (2027-2032)
  9. 7.5 Global Mesalazine API Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Mesalazine API Production Value (2021-2032)
  12. 7.6.2 Europe Mesalazine API Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Mesalazine API Production Value (2021-2032)
  14. 7.6.4 South America Mesalazine API Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Mesalazine API Production Value (2021-2032)
8 Global Mesalazine API Consumption by Region
  1. 8.1 Global Mesalazine API Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Mesalazine API Consumption by Region (2021-2032)
  3. 8.2.1 Global Mesalazine API Consumption by Region (2021-2026)
  4. 8.2.2 Global Mesalazine API Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Mesalazine API Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Mesalazine API Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Mesalazine API Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Mesalazine API Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Mesalazine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Mesalazine API Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalazine API Value Chain Analysis
  2. 9.1.1 Mesalazine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalazine API Production Mode & Process
  6. 9.2 Mesalazine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalazine API Distributors
  9. 9.2.3 Mesalazine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst